01.10.2014 • NewsDrug DeliveryAesica PharmaceuticalsAesica

Consort Medical to Acquire Aesica Pharmaceuticals

Consort Medica, a UK-based manufacturer of disposable medical devices for drug delivery, has announced it will acquire all shares of German-based Aesica Pharmaceuticals from private equity investor Silverfleet Capital for £230 million.

The deal is expected to be finalized in November, subject to approval by Consort shareholders and German competition authorities.

Aesica provides contract development and manufacturing services for finished dose and Active Pharmaceutical Ingredients, APIs, to the global pharmaceutical industry. Since its founding in 2004, the company has grown both organically and through acquisitions and has established key strategic relationships with major global blue-chip pharmaceutical companies.

Jon Glenn, CEO of Consort Medical, said Aesica is a "very strong fit" with the UK firm's strategy of diversifying into adjacent markets and technologies to capture additional value in the drug/device supply chain.

The German company also is "highly complementary" to the existing business of Consort's Bespak's drug delivery operating division and provides a number of clear strategic, competitive and value-enhancing benefits for the enlarged group, Glenn added.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.